Efficacy and Safety of Biosimilar SAR342434 Insulin Lispro in Adults with Type 2 Diabetes, Also Using Insulin Glargine: SORELLA 2 Study

por Derwahl, Karl-Michael, Bailey, Timothy S., Wernicke-Panten, Karin, Ping, Lin, Pierre, Suzanne
Publicado 2018

Efficacy, Safety, and Immunogenicity of Insulin Aspart Biosimilar SAR341402 Compared with Originator Insulin Aspart in Adults with Diabetes (GEMELLI 1): A Subgroup Analysis by Prio...

por Shah, Viral N., Franek, Edward, Wernicke-Panten, Karin, Pierre, Suzanne, Mukherjee, Bhaswati, Sadeharju, Karita
Publicado 2021

Safety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump

por Thrasher, James, Surks, Howard, Nowotny, Irene, Pierre, Suzanne, Rotthaeuser, Baerbel, Wernicke-Panten, Karin, Garg, Satish
Publicado 2018

Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes

por Home, Philip, Derwahl, Karl-Michael, Ziemen, Monika, Wernicke-Panten, Karin, Pierre, Suzanne, Kirchhein, Yvonne, Garg, Satish K.
Publicado 2018

Efficacy and Safety of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Treated for 26 Weeks with Multiple Daily Injections in Combinati...

por Garg, Satish K., Wernicke-Panten, Karin, Wardecki, Marek, Kramer, Daniel, Delalande, Francois, Franek, Edward, Sadeharju, Karita, Monchamp, Travis, Mukherjee, Bhaswati, Shah, Viral N.
Publicado 2020

Safety, Immunogenicity, and Glycemic Control of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Also Using Insulin Glargine: 12-Month R...

por Garg, Satish K., Wernicke-Panten, Karin, Wardecki, Marek, Kramer, Daniel, Delalande, Francois, Franek, Edward, Sadeharju, Karita, Monchamp, Travis, Miossec, Patrick, Mukherjee, Bhaswati, Shah, Viral N.
Publicado 2020

Efficacy, Safety, and Immunogenicity of Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Compared with Originator Insulin Aspart Mix 70/30 in Adults with Diabetes (GEMELLI M):...

por Aravind, S. R., Singh, Kiran P., Mogylnytska, Liliia, Zalevskaya, Alsu G., Matyjaszek-Matuszek, Beata, Wernicke-Panten, Karin, Nguyên-Pascal, My-Liên, Pierre, Suzanne, Rotthaeuser, Baerbel, Kramer, Daniel, Mukherjee, Bhaswati
Publicado 2022

Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (NovoMix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMEL...

por Aravind, S. R., Singh, Kiran P., Aquitania, Grace, Mogylnytska, Liliia, Zalevskaya, Alsu G., Matyjaszek-Matuszek, Beata, Wernicke-Panten, Karin, Nguyên-Pascal, My-Liên, Pierre, Suzanne, Rotthaeuser, Baerbel, Kramer, Daniel, Mukherjee, Bhaswati
Publicado 2022